483 Sergio D. Bergese Mar 2018

483 Sergio D. Bergese Mar 2018

Geoffrey Kilili FDA$119.00 - Available Now

FDA investigators audited the Sergio D. Bergese - Columbus, OH, United States facility and issued inspectional observations (via FDA 483) on 30 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 30 Mar 2018
  • Location: Columbus, United States
  • FEI: 3014197199
Add To Cart